Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Epigentek Group
AddedFeb 18, 2024
UpdatedJun 28, 2026
Epigentek Group

Epigentek Group

Public

Epigentek, founded in 2005, is a global leader in providing innovative, efficient, and cost-effective solutions for epigenetic-related research and drug discovery.

HQ
Farmingdale, NY, US
Founded
2005
Overview
Compare
Employees
Website

Epigentek, founded in 2005, is a global leader in providing innovative, efficient, and cost-effective solutions for epigenetic-related research and drug discovery. The company's core mission is to advance the field of epigenetics by developing comprehensive and proprietary products that offer systematic solutions for researchers. Epigentek's product portfolio includes kits and reagents for DNA methylation, histone modification, RNA epigenetics, and chromatin studies, catering to academic institutions, pharmaceuticals, and biotechnology companies worldwide.

Notable affiliated individuals include leading scientists and researchers in the field of epigenetics who utilize Epigentek's products for groundbreaking studies. The company has secured investments from prominent venture capital firms specializing in biotech innovations. Key achievements include the widespread adoption of their products in esteemed research institutions and significant contributions to drug discovery processes. Epigentek's impact is evident in its facilitation of advanced epigenetic research, driving scientific discoveries and therapeutic advancements globally.

Epigentek Group - Similar Companies

EpiCypher logo

EpiCypher

epicypher.com

Epic-Bio logo

Epic-Bio

epic-bio.com

Zymo Research logo

Zymo Research

zymoresearch.com

EpigenCare logo

EpigenCare

epigencare.com

Epigenos Biosciences logo

Epigenos Biosciences

Episona logo

Episona

Fluidigm logo

Fluidigm

standardbio.com

EndGenitor Technologies logo

EndGenitor Technologies

Durect logo

Durect

durect.com

Quadrant Biosciences logo

Quadrant Biosciences

Bio-Rad logo

Bio-Rad

bio-rad.com

Innovative Genetics logo

Innovative Genetics

AtlasXomics logo

AtlasXomics

atlasxomics.com

Alida Biosciences logo

Alida Biosciences

alidabio.com

EpiFluid logo

EpiFluid

Epigentek Group - Quick Facts

Who are Epigentek Group's competitors?

Companies similar to Epigentek Group include EpiCypher, Epic-Bio, Zymo Research and EpigenCare.

When was Epigentek Group founded?

Epigentek Group was founded in 2005.

Where is Epigentek Group's headquarters located?

Epigentek Group's headquarters is located in Farmingdale, NY, US.

How many employees does Epigentek Group have?

Epigentek Group has 7 employees as of Feb 10, 2024.

Epigentek Group - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Research
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
ISIC
  • 7210Research and experimental development on natural sciences and engineering
Show 11 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8731Commercial Physical and Biological Research